We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Assembling the Pieces of the Genomic Puzzle
Assembling the Pieces of the Genomic Puzzle
Blog

OmniTier Inc.’s new bioinformatics platform, CompStorTM Novos, takes a de novo assembly-based variant calling approach to the challenge of whole genome sequencing. We caught up with Jon Coker, Omnitier’s CTO, to discuss how this approach matches up to rival techniques, and how high-performance computing approaches like Omnitier’s hope to bring personalized medicine a step closer and boost biology in coming years.

Read More

What’s New in the Food Analysis Toolkit?
What’s New in the Food Analysis Toolkit?
Blog

In areas, such as food analysis where detection of contaminants may be imperative to prevent dangers to consumers, speed and reliability is key. We spoke to Tim Jenkins from Waters Corporation, about their coupling of DART to the QDa mass detector with a software solution aimed to enhance compound identification.

Read More

Immunotherapy Response Prediction in Urothelial Cancer
Immunotherapy Response Prediction in Urothelial Cancer
Blog

While immunotherapy holds great promise for cancer treatment, challenges persist around limited response rate and severe immune-related adverse events. We caught up with Dr. Georg Lautscham, CEO of Protagen, to find out how the prediction of immunotherapy response can be improved for people with urothelial cancer.

Read More

How to Buy Neuroscience Equipment
How to Buy Neuroscience Equipment
Blog

Lab equipment purchases, both big and small, require plenty of thought and can have a big impact on the quality of your science. In this blog, MCI Neuroscience's Adam Tozer highlights some tips to making the best purchases.

Read More

Accelerating the Development of Liver Gene Medicines
Accelerating the Development of Liver Gene Medicines
Blog

Recent technology advancements have enabled the opportunity to increase the efficiency, efficacy and safety of gene and cell-based medicines for a multitude of genetic disorders. To date, a major challenge facing the field has been the ability to deliver therapeutic genes to affected cell types. In this blog, Sarah Haecker Meeks and Michael Roberts from Synpromics outline the ways in which gene medicines can be optimized to overcome this barrier.

Read More

How AI Can Speed Up High Content Screening Analysis
How AI Can Speed Up High Content Screening Analysis
Blog

High content screeening (HCS) has become a staple tool for scientists trying to find out how molecules alter our cells' biological systems. The huge volume of data that HCS produces is both its strength and weakness. As assays become more complex, companies like Genedata are turning to AI-based approaches to help streamline HCS analysis. I spoke to Genedata's Head of Science, Dr. Stephan Steigele, to find out more.

Read More

 The Changing Shape of Optofluidics R&D
The Changing Shape of Optofluidics R&D
Blog

Life science businesses are facing growing demand to keep pace in an era of fast-evolving technology. By recognising the potential challenges, a growing number of companies are leveraging the resources and creativity of their suppliers. We took a look at the landscape of optofluidics R&D.

Read More

Developing Therapies to Fight Cancer and Autoimmune Diseases
Developing Therapies to Fight Cancer and Autoimmune Diseases
Blog

We recently spoke to Alexis Peyroles, CEO at OSE Immunotherapeutics to hear more about the findings of their recent study, describing, for the first time ever, the in vivo MOA of interleukin 7 receptor alpha (IL-7Rα) monoclonal antibodies, suggesting therapeutic efficacy in controlling chronic inflammation.

Read More

Candidate Drug Proposes a Botanical Solution to Neuropathic Pain
Candidate Drug Proposes a Botanical Solution to Neuropathic Pain
Blog

NeuroBo Pharmaceuticals’ first lead candidate, NB-01, is positioned as a potential treatment for diabetic neuropathic pain. The candidate, which in 2018 will move into a phase III clinical trial, uses extracts of two species of the plant genus Dioscorea, used in traditional medicine for centuries, but never yet subject to systematic study. We caught up with NeuroBo’s Mark Versavel and Nandan Padukone to find out more.

Read More

Entering the Golden Era of Lateral Flow Diagnostics
Entering the Golden Era of Lateral Flow Diagnostics
Blog

Gold nanorods are increasingly being used in diagnostic applications, such as lateral flow assays. To learn more, we got in touch with Darren Rowles, CEO of Sona Nanotech Inc. who provides insights on diagnostic industry trends, and tells us about the source, application and production process of gold nanoparticles.

Read More